Stock Research: Sigma Healthcare

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Sigma Healthcare

ASX:SIG AU000000SIG5
53
  • Value
    53
  • Growth
    50
  • Safety
    Safety
    28
  • Combined
    34
  • Sentiment
    74
  • 360° View
    360° View
    53
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Sigma Healthcare Limited is an Australian retail pharmacy franchisor and pharmaceutical wholesaler. It operates in the retail pharmacy and pharmaceutical distribution industries, with brands like Chemist Warehouse, My Chemist, Amcal, and Discount Drug Stores. It has a presence in Australia, New Zealand, Ireland, Dubai, and China. In the last fiscal year, the company had a market cap of $20,672 million, profits of $227 million, and revenue of $3,059 million. The number of employees is not available.

more
Index
ASX 100
ASX 200
ASX 300
ASX 50
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
53 1 14 39
Growth
50 99 100 3
Safety
Safety
28 30 32 39
Sentiment
74 33 18 6
360° View
360° View
53 25 18 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
43 1 17 14
Opinions Change
50 75 50 50
Pro Holdings
n/a 33 18 40
Market Pulse
64 70 30 27
Sentiment
74 33 18 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
53 1 14 39
Growth
50 99 100 3
Safety Safety
28 30 32 39
Combined
34 29 39 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
34 3 67 91
Price vs. Earnings (P/E)
16 3 3 41
Price vs. Book (P/B)
94 5 43 75
Dividend Yield
60 6 17 27
Value
53 1 14 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
54 100 100 41
Profit Growth
100 100 98 8
Capital Growth
46 29 75 1
Stock Returns
29 100 85 11
Growth
50 99 100 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
39 74 58 54
Refinancing
20 17 30 59
Liquidity
55 10 17 8
Safety Safety
28 30 32 39

Similar Stocks

Discover high‑ranked alternatives to Sigma Healthcare and broaden your portfolio horizons.

Kelsian

ASX:KLS
Country: Australia
Industry: Highways & Railtracks
Size: Medium
Full Stock Analysis

BML

TYO:4694
Country: Japan
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Ship Healthcare Holdings

TYO:3360
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Alfresa Holdings

TYO:2784
Country: Japan
Industry: Health Care Distributors
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: